Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia

American Journal of Ophthalmology

Volumn 137, Issue 2, 2004, Pages 367-368

  Jonas, Jost B ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE; TRIAMCINOLONE ACETONIDE;

ADRENAL DISEASE; ADULT; ANAMNESIS; ANTERIOR EYE CHAMBER DISEASE; ARTICLE; BONE FRAGILITY; CASE REPORT; CATARACT EXTRACTION; CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; CUSHING DISEASE; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDICATION; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE; MALE; OBESITY; PERIMETRY; PRIORITY JOURNAL; SYMPATHETIC OPHTHALMIA; SYMPTOM; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD; VITRECTOMY;

EID: 1242271206     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00899-7     Document Type: Article

References (5)

1. Machemer R., Sugita G., Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc. 77:1979;171-180.
2. Danis R.P., Ciulla T.A., Pratt L.M., Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 20:2000;244-250.
3. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 109:2002;920-927.
4. Nguyen N.X., Kuchle M., Naumann G.O. Tyndallometry in monitoring therapy of sympathetic ophthalmia. Klin Monatsbl Augenheilkd. 204:1994;33-36.
5. Jaffe G.J., Yang C.H., Guo H., et al. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci. 41:2000;3569-3575.